ARBPs topline grew ~12% YoY to Rs 38.6bn in 3QFY17. The EBITDA margin declined ~170bps QoQ and 45bps YoY to 23.2% on account of heightened pricing pressure (13%YoY) in the US. Reported PAT stood at Rs 5.8bn, up ~6%YoY.